SCHEMBL200076

SCHEMBL200076

N#CC(O)(Cl)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.46
CYP1A2 P05177 2/20 0.43
ATM Q13315 1/20 0.38
CYP2D6 P10635 2/20 0.37
DRD2 P14416 2/20 0.37
DRD4 P21917 2/20 0.37
OPRM1 P35372 2/20 0.37
DRD3 P35462 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP3A4 P08684 1/20 0.35
ALDH1A1 P00352 4/20 0.35
KCNN4 O15554 1/20 0.35
KCNA3 P22001 3/20 0.34
MAPT P10636 2/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101146 0.77 TSHR (0.42) TSHRCYP1A2ATMCYP2D6DRD2
SCHEMBL8362586 0.76 TSHR (0.52) TSHRCYP1A2ATMCYP2D6MEN1
SCHEMBL639889 0.75 ATM (0.41) TSHRCYP1A2ATMCYP2D6DRD2
SCHEMBL8755619 0.75 ALDH1A1 (0.41) TSHRCYP1A2ATMCYP2D6DRD2
SCHEMBL11143559 0.75 TSHR (0.50) TSHRCYP1A2ATMCYP2D6DRD2
SCHEMBL6846624 0.75 ATM (0.41) TSHRCYP1A2ATMCYP2D6DRD2
SCHEMBL5152927 0.75 TSHR (0.50) TSHRCYP1A2ATMCYP2D6DRD2
SCHEMBL28857197 0.73 ALDH1A1 (0.40) TSHRCYP1A2ATMCYP2D6DRD2
SCHEMBL10486722 0.73 TSHR (0.37) TSHRCYP1A2ATMCYP2D6DRD2
SCHEMBL7030622 0.72 MAPK1 (0.46) TSHRATMCYP2D6DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599584-A1 MODIFIED NITRILASES AND THEIR USE IN METHODS FOR THE PRODUCTION OF CARBOXYLIC ACIDS BASF AKTIENGESELLSCHAFT (DE) 2005-11-30 EP claimed
WO-2004076655-A1 MODIFIED NITRILASES AND THEIR USE IN METHODS FOR THE PRODUCTION OF CARBOXYLIC ACIDS BASF AKTIENGESELLSCHAFT (DE) 2004-09-10 WO claimed
EP-0527553-B1 Process for producing r(-)-mandelic acid and derivative thereof NITTO CHEMICAL INDUSTRY CO LTD (JP) 1997-05-07 EP claimed
US-5296373-A Stereoselective hydrolysis of mandelonitrile in neutral or basic aqueous medium NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1994-03-22 US claimed
EP-0527553-A1 Process for producing r(-)-mandelic acid and derivative thereof NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1993-02-17 EP claimed
US-9828594-B2 Nitrilases, nucleic acids encoding them and methods for making and using them BASF ENZYMES LLC (US) 2017-11-28 US disclosed
US-20160355801-A1 NITRILASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM VERENIUM CORPORATION 2016-12-08 US disclosed
US-9315792-B2 Nitrilases, nucleic acids encoding them and methods for making and using them BASF ENZYMES LLC (US) 2016-04-19 US disclosed
US-9217164-B2 Nitrilases, nucleic acids encoding them and methods for making and using them BASF ENZYMES LLC (US) 2015-12-22 US disclosed
EP-2327766-B1 Nitrilases BASF ENZYMES LLC (US) 2015-12-02 EP disclosed
EP-2319919-B1 Nitrilases BASF ENZYMES LLC (US) 2015-08-12 EP disclosed
EP-1576108-B1 NITRILASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM BASF ENZYMES LLC (US) 2015-07-08 EP disclosed
WO-2003097810-A2 NITRILASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM DIVERSA CORPORATION (US) 2003-11-27 WO disclosed
WO-2003098187-A2 ASSAYS AND KITS FOR DETECTING THE PRESENCE OF NITRILES AND/OR CYANIDE DIVERSA CORPORATION (US) 2003-11-27 WO disclosed
US-20030124698-A1 Which stereoselectively hydrolyze nitrites or cyanohydrins into acids and ammonia DIVERSA CORPORATION 2003-07-03 US disclosed
WO-2003000840-A2 NITRILASES DIVERSA CORPORATION (US) 2003-01-03 WO disclosed
EP-0527553-B1 Process for producing r(-)-mandelic acid and derivative thereof NITTO CHEMICAL INDUSTRY CO LTD (JP) 1997-05-07 EP disclosed
CN-1033142-C A process for preparing pharmaceutical composition showing properties in against human immunodeficiency virus JANSSEN PHARMACEUTICA NV (BE) 1996-10-30 CN disclosed
US-5296373-A Stereoselective hydrolysis of mandelonitrile in neutral or basic aqueous medium NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1994-03-22 US disclosed
EP-0527553-A1 Process for producing r(-)-mandelic acid and derivative thereof NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1993-02-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030124698-A1 Which stereoselectively hydrolyze nitrites or cyanohydrins into acids and ammonia NIT2, DNPH1, ASNS TSHR 4562/4885CYP1A2 1283/4885ATM 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.